WCT Worldwide Clinical Trials GER
WCT Worldwide Clinical Trials GER is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
Randomized, double-blind, placebo-controlled, multicenter Phase 2 trial assessing the effect of IMU-838 on disease activity, as measured by magnetic resonance imaging (MRI), as well as safety and tolerability in patients with relapsing-remitting multiple sclerosis (RRMS)
Sponsor Immunic AG
- Start (EU)
- Latest update
- Estimated end
Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of NT 201 in the treatment of lower limb spasticity caused by stroke or traumatic brain injury in adult subjects, followed by an open label extension with or without combined upper limb treatment
Sponsor Merz Pharmaceuticals GmbH
- Start (EU)
- Latest update
- Estimated end
A Placebo-Controlled, Double-Blind, Parallel-Group, 18 Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease
Sponsor Eisai Limited
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for WCT Worldwide Clinical Trials GER?
The 2026-10-09 snapshot links WCT Worldwide Clinical Trials GER to 3 distinct CTIS trials. Recorded services include Safety reporting & pharmacovigilance, Clinical monitoring, Investigator recruitment, Regulatory services, among 6 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for WCT Worldwide Clinical Trials GER?
The most frequently recorded therapeutic areas are Immunology, Neurology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to WCT Worldwide Clinical Trials GER conducted?
The linked trials record locations in 12 countries, including Germany, Spain, France, Italy, Poland. These are trial locations, not confirmed office locations or countries where WCT Worldwide Clinical Trials GER delivered services.
What can this page tell me about WCT Worldwide Clinical Trials GER's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under WCT Worldwide Clinical Trials GER. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- WCT Worldwide Clinical Trials GER GmbH